Publicado 05/12/2013 09:46
- Comunicado -

New Data Support Flexibility in Timing of Administration for Sanofi's Lyxumia® (y 2)

CONTACT: Media Relations: Jack Cox, Tel.: +(33)1-53-77-46-46,mr@sanofi.com; Investor Relations: Sébastien Martel, Tel.:+(33)1-53-77-45-45, ir@sanofi.com

Contenido patrocinado